A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus
Condition:   Systemic Lupus Erythematosus Interventions:   Drug: Mosunetuzumab;   Drug: Tocilizumab Sponsor:   Hoffmann-La Roche Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2021 Category: Research Source Type: clinical trials